| Basics |
ZOETIS INC.
Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
|
| IPO Date: |
February 1, 2013 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers |
| Market Cap: |
$52.29B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.12 | 0.99%
|
| Avg Daily Range (30 D): |
$1.41 | 1.12%
|
| Avg Daily Range (90 D): |
$1.39 | 0.99%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.48M |
| Avg Daily Volume (30 D): |
3.87M |
| Avg Daily Volume (90 D): |
2.9M |
| Trade Size |
| Avg Trade Size (Sh.): |
93 |
| Avg Trade Size (Sh.) (30 D): |
58 |
| Avg Trade Size (Sh.) (90 D): |
55 |
| Institutional Trades |
| Total Inst.Trades: |
26,219 |
| Avg Inst. Trade: |
$7.84M |
| Avg Inst. Trade (30 D): |
$11.37M |
| Avg Inst. Trade (90 D): |
$12.8M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
8 |
| Market Closing Trades |
| Avg Closing Trade: |
$33.44M |
| Avg Closing Trade (30 D): |
$74.05M |
| Avg Closing Trade (90 D): |
$65.45M |
| Avg Closing Volume: |
290.88K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$5.94
|
$1.63
|
$1.61
|
|
Diluted EPS
|
$5.94
|
$1.63
|
$1.61
|
|
Revenue
|
$ 9.4B
|
$ 2.4B
|
$ 2.46B
|
|
Gross Profit
|
$ 6.74B
|
$ 1.72B
|
$ 1.81B
|
|
Net Income / Loss
|
$ 2.65B
|
$ 721M
|
$ 718M
|
|
Operating Income / Loss
|
$ 3.33B
|
$ 887M
|
$ 902M
|
|
Cost of Revenue
|
$ 2.66B
|
$ 683M
|
$ 649M
|
|
Net Cash Flow
|
$ 370M
|
$ 649M
|
$ -286M
|
|
PE Ratio
|
19.97
|
|
|
|
|
|
